NeuroSense Therapeutics Ltd.

US$1.68As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:NRSNHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (50.13%)
Div yield —
ROE (2174.98%)
Biotechnology
Beta (5Y) 1.72
PE TTM —
TSR TTM (92.50%)
Mkt cap US$3.106M
ROIC (1094.49%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.90
13.25%
112.16%
Sell 2|10|7|11|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.03
0.03
33.33%
26.62%
23.97%
19.36%
Revenue$M
0.282
0.279
0.293
0.309
(6.22%)
(5.10%)
1.96%
7.56%
Peers (US$3.106M)
Cap (US$)
PE
4.606M
—
2.854M
—
Capital
TTM
5Y
10Y
Leveragex
0.309
0.109
0.066
EBIT/Intx
0.993
0.316
0.276
Own earn%
(27.60)
(35.75)
(18.89)
Sh yield%
16.34
58.60
57.80
Owners
Insiders/Inst%
4.70
80.66
Short interest%
2.47
SBC / revenue%
3.06
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
1–6
$1 testx
−0.2
Incr. ROIC%
20